Search
Close this search box.

Lexington Clinic Grand Rounds

Lexington Clinic Grand Rounds

Course Description:
This regularly scheduled series will provide new clinical information on topics relevant to best practices of physicians administering clinical care in a wide range of specialties across Kentucky.

Statement of Need:
Physicians need to obtain new information related to clinical treatment and new/changes to clinical guidelines.

Objectives, Topics and Disclosure Information:
Physicians attending this conference regularly will be apprised of recent advances in medicine that will lead to improved patient care.

Session specific topic objectives are listed below and will be updated as content is developed.

Month

Presenter

Date of
Presentation

Links to Educational Activities
and Evaluations

Objectives

Disclosure*

February

Dr. Marisa Belcastro

2/15/2023

Treatment of Obesity from Start to Finish Using
GLP-1 Medications

Click below to
access video:
https://bit.ly/3xMFZ6m

Click below to access evaluation:
http://bit.ly/3xQoS3O

Be able to apply techniques to:

  • Accurately dx /assess obesity

Begin conversations with patients regarding:

  • Recommend lifestyle changes with evidence backing
  • Properly begin medication assisted treatment for obesity with GLP-1

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

March

Dr. Alexander Patterson

3/15/2023
at noon EST

Adverse Reactions to Vaccines

Click below to
access video:
https://bit.ly/40jqWxd

Click below to access evaluation:
http://bit.ly/3Z0d5ef

  • Review the basic immunology behind vaccination
  • Understand the epidemiology and etiologies of Type 1 hypersensitivity reactions following vaccination.
  • Understand the utilities and limitations of of traditional drug allergy evaluation methods in regards to COVID-19 vaccination.
  • Understand alternate etiologies for vaccination adverse events, apart from true allergy.​

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

April

Dr. Christian Warner

4/19/2023

 

Diabetic Retinopathy

Click below to access video:
bit.ly/43RCavs

Click below to access evaluation:
bit.ly/3Nas6rr

 

  • Identify risk factors for development of diabetic retinopathy
  • Become familiar with stages and types of diabetic retinopathy
  • Apply current treatment option for diabetic retinopathy

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

May

Dr. Eric Schmidt

5/17/2023

 

Overview of Surgical Indications & Approaches to Degenerative Spinal Pathology

Click below to access video:
https://bit.ly/3OA7Sbp

Click below to access evaluation:
bit.ly/3LXib6v

 

  • Review the degenerative cascade occurring in the aging spine
  • Discuss cervical and lumbar specific degenerative pathology and its clinical relevance
  • Review conservative treatment options and surgical indications
  • Provide an overview and comparison of commonly-employed surgical techniques for cervical and lumbar degenerative pathology

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

June

Dr. Haider Abbas

6/21/2023

 

79 Year-Old Female with “Heavy Arms” – Understanding Large Vessel-GCA

Click below to access video:
bit.ly/48ub2Es

Click below to access evaluation:
 bit.ly/4569y1z

 

Be able to define vasculitis
Describe classification criteria
Describe the clinical manifestations of vasculitis
Apply diagnostic work-up of vasculitis
Describe and apply treatment modalities for systemic vasculitides

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

July

Dr. Andrea Colton, MPH

7/19/23

 

Current Trends in Breast Cancer

Click below to access video:
bit.ly/3Dt5MDs

Click below to access evaluation:
bit.ly/477qsyr

Describe what imaging studies to order and when
Outline and describe surgical options
Describe how to implement correct guidelines and implement de-escalation of care
Describe emerging research and technology associated with care

The following planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Haider Abbas, M.D., Miranda Mosley, and Rachel Crouch.

The following speakers disclose that they have that they relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Andrea Colton, M.D.: 

Myriad Genetics, Advisory Board

Aptitude Health, Advisory Board

Kubtec, Speaker

All relevant relationships for this individual have been mitigated.

August

Tharun Karthikeyan, M.D.

8/16/23

 

Risks of Pre-Operative Opioid Use in Total Joint Arthroplasty

Click below to access video:
https://bit.ly/3OKkZ8p

Click below to access evaluation:
https://bit.ly/3P59YQs

Understand the risks associated with pre-operative opioid medications in total joint arthroplasty.

Discuss the mechanisms of action of opioid medications and risks in total joint arthroplasty.

Describe effective management of musculoskeletal pain utilizing TJA and decreasing use of opioids.

The following planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Haider Abbas, M.D., Miranda Mosley, and Rachel Crouch.

The following speakers disclose that they have that they relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Tharun Karthikeyan, M.D.: 

ZimmerBiomet, Educational consultant

All relevant relationships for this individual have been mitigated.

September

Dr. Clarissa Beiting

9/20/23

 

The Workup of the Abnormal Uterine and Vaginal Bleeding

Click below to access video:
https://bit.ly/3LElnVo

Click below to access evaluation:
https://bit.ly/3Zy7A8q

  • Determine the best course of action to triage for the female with abnormal uterine or vaginal bleeding
  • What iatogenic causes of uterine bleeding exist and how to triage those patients
  • Key parts of the pelvic exam to determine source of bleeding and who needs to be referred to Gynecologist
  • Types of vaginal bleeding
  •  

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

October

Dr. Shailendra Chopra

10/18/23

 

PET CT – Types & Uses In Practice

Click below to access video:
https://bit.ly/3FJxIUB

Click below to access evaluation:
https://bit.ly/40jzAgA

  • Enumerate various types of PET CT in practice.
  • Describe applications of PET CT.
  • Ensure that PET CT can be ordered correctly.

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

November

Dr. M. Jason Zimmerman, M.D., MSPH, FACC

11/15/23

 

Cardiac Amyloidosis

Click below to access video:
https://bit.ly/3MNGoxo

Click below to access evaluation:
https://bit.ly/3MNBOit

  • Understand the signs and symptoms of cardiac amyloidosis
  • Describe steps to take in the diagnoses of cardiac amyloidosis
  • Discuss the treatment options for cardiac amyloidosis

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

 

 

December NO SESSION

*All planners discloses that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Commercial Support: There is no commercial support associated with this activity.

Accreditation and Designation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a Joint Providership of the Kentucky Medical Association and the Lexington Clinic. The Kentucky Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Kentucky Medical Association designates this enduring material activity for 1.oo AMA PRA Category 1 credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Estimated Time to Complete: This module will take approximately 1 hour to complete

Method of Participation Used: Participants will view and listen to a recorded lecture while simultaneously viewing slides.

Hardware/Software Requirements: High speed internet connection

Meeting Planner: Miranda Mosley, Rachel Crouch

Provider Contact Information: Miranda Mosley, Kentucky Medical Association

Copyright: There is no copyright associated with this activity

Release Date: January 2023

Termination Date: December 2023